Who We Serve
Everyone who brings science to market
Science is hard to sell well. The buyers are hard to find, decide as a committee, and trust evidence over marketing. We spent fifteen years selling into this market, and built the system around what it takes.
Every stakeholder sells to another
Developers buy from service providers, are funded by investors and are often born in academic labs. One map of the whole market serves all four, and this is the order of our focus.
Life-science service providers
CROs, equipment and technology makers, lab supply, software and diagnostics, reaching the drug developers who need them. We build the whole commercial system: the market mapped, outreach across the buying committee, and the pipeline.
Therapeutic developers
Teams moving a therapy toward market, keeping investors, partners and the field convinced along the way. We build marketing, intelligence and planning, with the technical precision their audience demands.
Academic labs spinning out a product
Research becoming a company, with no commercial team and no map of its market. We build the commercial system before the commercial team: partners and customers mapped, and a pathway to market.
Financial teams evaluating the market
Investors who need to see a scattered market clearly, across trials, grants, patents and filings. We bring our intelligence to deal flow and diligence.
From a founder alone to an enterprise in its own cloud
We build for commercial teams of any size. The method is the same for each; what changes is how deep it goes and where it's hosted.
A real product and no commercial system
Often a scientist carrying the selling alone. The whole system, stood up and run alongside them.
A team and tools that don't talk to each other
A commercial team of a few people to a few dozen. One connected system in place of the stack.
Its own cloud, sign-on and data rules
A CRM and tools already in place. The system built inside their environment and plugged into what they run.
Selling science is different
Standard B2B lead generation doesn't work in this market. Each of these is a reason, and each has an answer built into the system.
The market is small and specific
Awareness is worthless if it doesn't reach the qualified scientific audience, and broad reach mostly buys the wrong attention.
Depth over width: every account that matters, mapped, classified and scored.
The buyers are hidden
Specialists who don't see themselves as customers, researchers siloed inside large pharma, early-stage biotechs working quietly.
We find them through the public record: trials, grants, patents, papers, filings and hires.
A committee decides
Scientists, executives, procurement and regulatory each weigh a different part of the purchase, with real power over it.
The committee is mapped on the account, and each person is reached on what they weigh.
The science has to be right
Claims have to satisfy experts who demand detail, and stay inside the rules that limit what can be promoted.
Written from your own context and the market's own language. Nothing is invented.
The cycle is long
Months and often more than a year, with many touches before an opportunity exists. Today's marketing shows up in next year's revenue.
Every touch is written back to the account, so the whole cycle is run and measured as one.
Every deal is large
Missing one opportunity can cost more than a year of marketing, while generic platforms spend budget on reach that never qualifies.
Precision over volume: scored accounts, and signals that say when one is moving.
The noise
AI-written content floods every channel. It misses the technical nuance a scientist looks for, and it wears down trust.
Written in your team's own voice, specific and technical, and a person sends it.
Expertise stays invisible
The leaders who know the most have the least time to share it, while competitors win the mindshare.
A content system carries their thinking to the market in their own voice, on a steady rhythm.
Teams are thin
Budgets and teams are small next to the industry's giants, and every dollar has to show what it did for pipeline.
One connected system in place of a stack of vendors and tools, at any size.
Link the right people to the right solutions
Our goal for every client is to use this intelligence to link the right people to the solutions on offer. We don't game the system.
We enrich accounts and align them to the value propositions and the pain points, do the market research to understand the people, and align to their personas, to understand what matters to each of them in their role.
Then we use all of it to establish connections and real partnerships, built on trust, understanding and peer-to-peer credibility.
It's why we can build for this market. The method came from fifteen years of selling into life sciences, and our own intelligence holds the market already classified by modality, phase, therapeutic area and funding.
As AI platforms make the plumbing cheap, what holds its value is the domain, the method and the curated intelligence. That's where we put our depth.
Before anyone reaches out, the system knows the account
People in this market buy from partners they trust, and trust comes from understanding. Those are what a Miller Heiman account and opportunity plan hold.
The company's challenges
Its operational and strategic hurdles.
What each decision maker counts as a win
The result each person needs personally, as well as the company's.
The technical requirements
The science and the technical needs of the program.
The regulatory constraints
The compliance landscape the purchase has to fit.
The competitive pressures
The alternatives on the table, and how the offer stands against them.
Inside every account, a committee
We align to each person's persona, to understand what matters to them in their role. Who holds the budget or the veto is learned in conversation, never assumed from a title.
Executive leadership
They weigh strategic impact, return and competitive advantage. What earns their trust is a clear account of what it changes for the business, in business terms.
Vice presidents and directors
They weigh their own function's efficiency and the work of putting something in place. An implementation plan and the value to their team earn theirs.
Scientific experts
They weigh the method and the validity of the data. Technical documentation, demonstrations and the judgment of their peers earn theirs.
Regulatory and quality leaders
They weigh compliance and risk. The documentation, the validation process and the certification pathway earn theirs.
Procurement
They weigh terms, budget and vendor qualification. A clear qualification and a path through their buying system earn theirs.
Real relationships, from the top of the funnel through the pipeline
From the top of the funnel through the pipeline, the system matures those relationships over time: a system designed for this market and these buyers.
Outbound reaches the accounts that matter, signal-based outreach the accounts that are moving, and inbound the people who come on their own. All three feed the same pipeline.
Miller Heiman is our standardized pipeline, and the aim is one system that tracks from the cold lead to the closed deal. The result: prospects see partners, not vendors.
See what it looks like for you
Next step
Bring us your market. We'll show you the system.
Every engagement starts the same way: one working session on your market, your buyers and your goals, before anyone proposes anything.